Yes, the answer could be as simple as that. i a
Post# of 148288
(Total Views: 545)
Posted On: 01/19/2021 1:42:21 PM
Yes, the answer could be as simple as that.
i am clueless as to the FDA protocols.
But it seems to me that its not too complicated to do a phase 1 trial with twenty patients and very close monitoring of RO with intravenous dosing.
But becasue of the Patterson/Pourhassan split, Cytodyn couldn't do that.
i am clueless as to the FDA protocols.
But it seems to me that its not too complicated to do a phase 1 trial with twenty patients and very close monitoring of RO with intravenous dosing.
But becasue of the Patterson/Pourhassan split, Cytodyn couldn't do that.
(0)
(1)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼